chr5-150302261-T-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001012301.4(ARSI):c.113A>T(p.Gln38Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001012301.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive spastic paraplegia type 66Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ARSI | ENST00000328668.8 | c.113A>T | p.Gln38Leu | missense_variant | Exon 1 of 2 | 1 | NM_001012301.4 | ENSP00000333395.7 | ||
| ARSI | ENST00000515301.2 | c.-118-3649A>T | intron_variant | Intron 1 of 1 | 4 | ENSP00000426879.2 | ||||
| ARSI | ENST00000509146.1 | c.-118-3649A>T | intron_variant | Intron 1 of 1 | 4 | ENSP00000420955.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a ARSI-related disease. This sequence change replaces glutamine with leucine at codon 38 of the ARSI protein (p.Gln38Leu). The glutamine residue is weakly conserved and there is a moderate physicochemical difference between glutamine and leucine. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. In summary, this variant is a novel missense change that is not predicted to affect protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at